About
We focus on the genetic diagnosis, understanding the underlying pathogenic mechanisms of disease, and the development of genetic treatments for conditions with late-onset, progressive hearing and vision loss (DFNA9/21/22; USH2a/2c/1d/1f).
Aims
- Developing RNA therapies for otogenetic disorders
- Developing personalized ‘n-of-1’ treatments for ultra-rare variants
- Improving delivery of therapeutic molecules to the inner ear
- Generation and characterization of innovative models for otogenetic disorders
- Unraveling regeneration pathways in zebrafish
Research programs
Programs that are connected to this research group.